ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

NEAL HERMANOWICZ MD

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,744Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 783

$1.5M Total Retail Price of All Prescriptions

Rank: 15 out of 783

516 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 5,104 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$261 was the average price of a prescription from this provider, compared to $231 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
CARBIDOPA-LEVODOPA 2,041 1,853 10 1 1
AZILECT 392 343 2 11
PRAMIPEXOLE DIHYDROCHLORIDE 364 324 3 8
DONEPEZIL HCL 190 186 4 2
AMANTADINE 187 131 5 27
ROPINIROLE HCL 147 136 6 10
EXELON 129 129 7 12
CLOZAPINE 128 128 8 117
REQUIP XL 122 88 10 9 89
SELEGILINE HCL 116 90 10 66
TRAZODONE HCL 97 91 11 36
XENAZINE 73 28 12 91
PRIMIDONE 72 72 13 13
CARBIDOPA-LEVODOPA-ENTACAPONE 69 57 14 90
MIRTAZAPINE 64 64 15 41
GABAPENTIN 63 58 16 3
NAMENDA 60 60 17 4
SERTRALINE HCL 57 44 18 26
PYRIDOSTIGMINE BROMIDE 57 57 18 95
STALEVO 100 57 51 18 81
QUETIAPINE FUMARATE 54 45 21 23
COMTAN 50 50 22 39
LEVETIRACETAM 50 50 22 5
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 14, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.